Research Scientific
IPAMORELIN + CJC-1295 (MOD GRF 1–29) BLEND – Research Grade Peptide
IPAMORELIN + CJC-1295 (MOD GRF 1–29) BLEND – Research Grade Peptide
Couldn't load pickup availability
IPAMORELIN + CJC-1295 (MOD GRF 1–29) BLEND – Research Grade Peptide
For research purposes only
This product is supplied exclusively for scientific laboratory research and analytical purposes. It is not intended for human or animal use, consumption, clinical use or therapeutic application.
It must not be used in any way that contravenes applicable laws or the requirements of the Medicines and Healthcare products Regulatory Agency. Research Scientific does not provide advice or recommendations concerning dosage, administration or use in humans or animals.
These restrictions apply to both Regular and ULTIMATE products.
- Research-grade Ipamorelin and CJC-1295 (MOD GRF 1–29) blend supplied exclusively for laboratory use.
- Supplied as lyophilised powder in flip-top headspace vials.
- Equal-mass formulation, with batch documentation available where supplied.
Research Scientific supplies this two-component peptide blend for controlled laboratory handling and analytical work. Review the product label and applicable batch documentation for the component quantities, formulation and specification of the selected vial.
Chemical Information
Chemical Information – Ipamorelin Component
- Component name: Ipamorelin.
- Synonym, as supplied: Ipamorelin Acetate.
- Chemical Abstracts Service registry number, as supplied: 170851-70-4.
- Molecular formula, as supplied: C38H49N9O5.
- Molecular weight: Not supplied.
Chemical Information – MOD GRF 1–29 Component
- Component name: MOD GRF 1–29.
- Synonyms, as supplied: CJC-1295 without DAC; Modified GRF 1–29.
- Chemical Abstracts Service registry number, as supplied: 863288-34-0.
- Molecular formula, as supplied: C152H252N44O42.
- Molecular weight: Not supplied.
Component specification: The chemical details above are retained from the supplied product information. Confirm that each synonym, registry number and formula corresponds to the exact component supplied, including the Ipamorelin acetate designation and the CJC-1295 without DAC description. Molecular weights have not been inferred.
These formulae are presented for the individual components, not as a molecular formula for the complete blend. No numerical purity is specified in the supplied description. Refer to the manufacturer's specification and completed batch documentation for the component identities, chemical forms and analytical results.
ULTIMATE IPAMORELIN + CJC-1295 (MOD GRF 1–29) Blend
Additional chromatographic purification and more stringent endotoxin testing
The ULTIMATE range is intended for laboratories requiring additional preparative high-performance liquid chromatography purification and a more stringent bacterial endotoxin testing specification for lipopolysaccharides. For this blend, confirm the product-specific purification process and testing requirements for the selected batch, including whether results cover the individual components, the finished blend or both.
Additional Purification
Review the documented additional preparative high-performance liquid chromatography stage and whether it is performed on the components or the finished blend.
More Stringent Endotoxin Testing
Confirm the analytical method, acceptance criteria and reported results against the product-specific ULTIMATE bacterial endotoxin specification.
Blend-Specific Documentation
Review the component identities, declared quantities, reported purity and endotoxin results for the selected grade and batch.
Regular or ULTIMATE?
Our Regular IPAMORELIN + CJC-1295 (MOD GRF 1–29) Blend remains a suitable choice for routine laboratory work where its documented specification meets the requirements of the intended method. Select ULTIMATE where the additional purification stage and more stringent endotoxin specification are required by your laboratory procedure.
Specification note: The ULTIMATE designation does not, by itself, establish a numerical purity, an endotoxin limit or sterility. Confirm the relevant specification and results in the applicable batch documentation.
Blended Peptides – Formulated for Laboratory Research
Defined component ratio: The stated formulation combines Ipamorelin and MOD GRF 1–29 in equal amounts by declared component mass. The stated blend weight refers to the combined declared quantity of both peptides in a single vial.
Illustrative composition: On this equal-mass basis, a 2-milligram total blend contains 1 milligram of Ipamorelin and 1 milligram of MOD GRF 1–29. This example illustrates the formulation ratio and does not indicate which vial sizes are available.
Check the product label and formulation records for the component quantities applicable to the selected vial size and any additional ingredients.
Formulation Process and Quality Assurance
Blend consistency: The formulation process is intended to support consistent component distribution throughout the vial contents. Review the manufacturing and analytical records for the declared quantities, blend specification and any supporting uniformity results.
Component and finished-blend documentation: Check which tests apply to the individual peptides and which apply to the finished formulation. Assess reported results against the stated analytical methods and acceptance criteria; component records alone should not be treated as results for the finished blend.
Manufacturing information: The supplied description refers to manufacture in a laboratory in the United Kingdom, the United States or Germany under quality-control protocols. Refer to the batch-specific supplier records for the actual manufacturing location and applicable quality documentation.
Laboratory Handling and Reconstitution
Laboratory presentation: The supplied product information describes sterile, lyophilised powder that has been finely milled and sieved, presented in sterile flip-top headspace vials. Confirm these processing and sterility specifications against the relevant manufacturing and batch records before relying on them for a laboratory procedure.
Reconstitution: The supplied description specifies bacteriostatic water containing 0.9% benzyl alcohol, or a suitable equivalent. Confirm that the selected medium is compatible with both components, the complete formulation and your laboratory's validated procedure.
Follow the product-specific instructions for laboratory handling, storage and disposal. Consult the Safety Data Sheet and applicable batch documentation before preparing the material.
Product Documentation and Delivery
Batch documentation: Available records can be accessed through the code on the packaging, where provided, or requested from Research Scientific. Match each document to the product name, selected grade and batch number.
View Certificate of Analysis template
The linked certificate currently displays an uncompleted template. Contact Research Scientific for a completed certificate identifying the selected Ipamorelin + CJC-1295 (MOD GRF 1–29) blend, grade and batch before relying on analytical results.
View IPAMORELIN + MOD GRF 1–29 Safety Data Sheet
The linked Safety Data Sheet identifies the blend under product code PEP080 but does not list the two components separately. Request the supporting component specifications and confirm that the safety documentation matches the exact formulation supplied.
Tracked delivery: Securely packaged and dispatched frozen in insulated packaging using a tracked delivery service. Follow the product's storage instructions upon receipt.
Share
